Messenger RNA expression of human toll like receptors 3, 7 and 9 in Peripheral blood of patients with Hepatitis B infection

Kaushal Yadav, Biswajyoti Borkakoty, Dipankar Biswas, Chandra Kanta Bhattacharya, Jagadish Mahanta

Abstract


Despite the availability of effective vaccine and antiviral therapy, hepatitis B remains a serious public health problem worldwide. In spite of tremendous work done in the past, some questions pertaining to hepatitis B biology is yet to be understood. For instance the molecular mechanism whereby host fails to eliminate the virus leading to persistent infection is clearly not known. As many works have been directed towards understanding adaptive immune response, the area of innate immunity is poorly explored. The aim of the present study was to elucidate the role of toll-like receptors, an important component of innate immunity, in patients with hepatitis B infection. The mRNA expression of TLRs were studied in a total of 51 hepatitis B patients (45 chronic and 6 hepatocellular carcinoma) and 45 healthy individuals hailing from Arunachal Pradesh of northeastern part of India by quantitative PCR in LC 480 (Roche) system utilizing SYBR green and in house designed primers. Expression of TLR3, TLR7 and TLR9 was increased by 1.09 and 1.11 fold respectively with significant increase in TLR9 mRNA (p=0.017) in chronic and HCC patients compared to healthy control. No significant association was found with TLR9 expression and serum HBV DNA load (r=0.0033, p=0.98).Significant association of TLR9 in hepatitis B patients show that TLR9 does play a key role in persistent HBV infection and hepatoceelular carcinoma.


Keywords


Hepatitis B, Toll-like receptor, qPCR

Full Text:

PDF

References


Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68

Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 28:20:24: 7707–17

World Health Organization. 2015. Fact Sheet, Hepatitis B, last updated July 2015.

http://www.who.int/mediacentre/factsheets/fs204/en/

Liang TJ. Hepatitis B: The Virus and Disease. Hepatology; 2009; 49 Suppl5: S13–S21

Zhang E, Lu M. Toll‑like receptor (TLR) -mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol 2015; 204:11–20

Isogawa M, Robek MD, FuruichiY, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005; 79:7269–72

Pei RJ, Chen XW, Lu MJ. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World J Gastroenterol 2014; 7: 20:33:11618-29

Centers for Disease Control and Prevention, Atlanta USA. Hepatits B, acute, 2012 case definition. Last updated May 06, 2015

Centers for Disease Control and Prevention, Atlanta USA. Hepatits B, Chronic, 2012 case definition. Last updated May 06, 2015

Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008; 3:1101-08

Xu N, Yao HP, Sun Z, Chen Z. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacologica Sinica 2008; 29, 239-44

Zhou J, Huang Y, Tian D, Xu D, Chen M, Wu H.. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong. Univ Sci Technolog Med Sci 2009; 29:3:313–17

Xie Q, Shen HC, Jia NN, Wang H, Lin LY, An BY. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 2009; 11:4:515-23

Sajadi SMA, Mirzaei V, Hassanshahi G, Khorramdelazad H, Daredor HY, Hosseini SMH et al.Decreased Expressions of Toll-Like Receptor 9 and its Signaling Molecules in Chronic Hepatitis B Virus–Infected Patients. Arch Pathol Lab Med 2013;137:1674-79

Medhi S, Deka M, Deka P, Swargiary SS, Hazam RK, Sharma MP et al; 2011. Promoter region polymorphism & expression profile of toll like receptor3 (TLR3) gene in chronic hepatitis C virus (HCV) patients from India. Indian J Med Res 2011; 134:2: 200–07

Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, Wiley K. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol 2014; 61:1:38-43

Funk TE, Kottilil S, Gilliam B, Talwani R. Tickling the TLR7 to cure viral hepatitis. J Transl Med 2014; 12:129

Bhardwaj N. TLR AGONISTS: Are They Good Adjuvants? Cancer J 201016;4:382–91




DOI: http://dx.doi.org/10.7439/ijbar.v8i3.3954

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 International Journal of Biomedical and Advance Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.